1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES AND EXCHANGE ACT OF 1934
August 14, 2001
--------------------------------------------------------------------------------
Date of Report (Date of earliest event reported)
--------------------
NEOTHERAPEUTICS, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 000-28782 93-0979187
---------------------------- ------------------------ ----------------------
(State or other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification Number)
157 TECHNOLOGY DRIVE
IRVINE, CALIFORNIA 92618
--------------------- ----------
(Address of principal (Zip Code)
executive offices)
(949) 788-6700
(Registrant's telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
2
ITEM 5. OTHER EVENTS
On August 14, 2001, NeoTherapeutics, Inc. ("NeoTherapeutics") issued 600,000
shares of common stock to an institutional investor for aggregate consideration
of $2,010,000. The shares were issued pursuant to an effective Registration
Statement on Form S-3. The negotiated purchase price per share was $3.35. The
foregoing description is qualified in its entirety by reference to the Stock
Purchase Agreement, dated as of August 14, 2001, by and between the Registrant
and Summit Capital Management LLC, a copy of which is attached hereto as Exhibit
10.1.
ITEM 7. EXHIBITS
Exhibits:
10.1 Stock Purchase Agreement dated as of August 14, 2001, by and
between the Registrant and Summit Capital Management LLC.
2
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NEOTHERAPEUTICS, INC.
Date: August 14, 2001 By: /s/ Samuel Gulko
------------------------
Name: Samuel Gulko
Title: Chief Financial Officer
3
4
EXHIBIT INDEX
Exhibits:
--------
10.1 Stock Purchase Agreement dated as of August 14, 2001, by and
between the Registrant and Summit Capital Management LLC.